Patent · US Active

Use of triplex structure DNA in transferring nucleotide sequences

US8367068B2 · kind B2 · utility

5Cited by

1References

26Claims

0Family size

Assignees

INSTITUT PASTEUR · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Pierre Charneau · Paris, FR
Veronique Zennou · Paris, FR
Hüseyin Firat · Paris, FR

Key dates

Filing date	Jun 10, 2010
Grant date	Feb 5, 2013
Priority date	—
Expiry date	Jul 26, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/203
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method to induce an immune response in a host in need thereof, comprises administering to the host, recombinant lentiviral vector particles comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.